Mylan Announces Exclusive Distribution Partnership with Humeca

Mylan Announces Exclusive Distribution Partnership with Humeca Mylan Inc. MYL today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products. Humeca, which is based in the Netherlands, has a portfolio that includes products used by burn, plastic and reconstructive surgeons to repair skin defects.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsContractsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!